ADPT Sale Disclosure
Rubinstein Julie · SEC Form 4 · Filed Oct 29, 2026
Sale
Calculated transaction value
$244.49K
Rubinstein Julie President And COO
Transaction date
Oct 27, 2026
Public filing date
Oct 29, 2026
Filing lag
Filed 2 days later
ADPT daily price context
Close on/before transaction
$27.66
Oct 27, 2026
First close after public filing
$26.64
Oct 30, 2026
Return after filing · so far
+5.03%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,881 shares @ $27.53
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780664-26-000047
Filing cohort
Transactions in this filing
Showing 11 of 11
Trades
11
Issuers
1
Estimated value
$1.43M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 29, 2026 | $335.88K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 29, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 29, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 28, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 28, 2026 | $332.21K |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 28, 2026 | $5.78K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 28, 2026 | $144.24K |
| Adaptive Biotechnologies Corp ADPT Current | Sale | Oct 27, 2026 | $244.49K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 27, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Sale | Oct 27, 2026 | $79.74K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Oct 27, 2026 | $144.24K |